86.41
前日終値:
$85.96
開ける:
$86.08
24時間の取引高:
4.11M
Relative Volume:
0.83
時価総額:
$49.72B
収益:
$6.30B
当期純損益:
$1.07B
株価収益率:
46.95
EPS:
1.8406
ネットキャッシュフロー:
$1.09B
1週間 パフォーマンス:
+0.68%
1か月 パフォーマンス:
+6.33%
6か月 パフォーマンス:
-0.36%
1年 パフォーマンス:
+11.10%
Edwards Lifesciences Corp Stock (EW) Company Profile
名前
Edwards Lifesciences Corp
セクター
電話
(949) 250-2500
住所
ONE EDWARDS WAY, IRVINE, CA
Compare EW vs ABT, SYK, MDT, BSX
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
EW
Edwards Lifesciences Corp
|
86.35 | 49.50B | 6.30B | 1.07B | 1.09B | 1.8406 |
|
ABT
Abbott Laboratories
|
85.34 | 150.32B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
306.58 | 117.93B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
73.72 | 97.02B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
48.26 | 72.99B | 20.62B | 3.56B | 3.48B | 2.3847 |
Edwards Lifesciences Corp Stock (EW) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-04-01 | アップグレード | Wolfe Research | Peer Perform → Outperform |
| 2026-01-09 | アップグレード | TD Cowen | Hold → Buy |
| 2025-12-18 | アップグレード | JP Morgan | Neutral → Overweight |
| 2025-11-03 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2025-10-29 | アップグレード | Jefferies | Hold → Buy |
| 2025-10-29 | アップグレード | Wolfe Research | Underperform → Peer Perform |
| 2025-10-08 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2025-10-07 | アップグレード | Evercore ISI | In-line → Outperform |
| 2025-07-29 | アップグレード | BTIG Research | Neutral → Buy |
| 2025-04-24 | アップグレード | Piper Sandler | Neutral → Overweight |
| 2025-01-30 | アップグレード | Stifel | Hold → Buy |
| 2025-01-16 | ダウングレード | Wolfe Research | Peer Perform → Underperform |
| 2024-12-16 | アップグレード | BofA Securities | Neutral → Buy |
| 2024-10-11 | 再開されました | Morgan Stanley | Equal-Weight |
| 2024-09-18 | ダウングレード | Jefferies | Buy → Hold |
| 2024-07-31 | アップグレード | Daiwa Securities | Neutral → Outperform |
| 2024-07-29 | アップグレード | Wolfe Research | Underperform → Peer Perform |
| 2024-07-25 | ダウングレード | BofA Securities | Buy → Neutral |
| 2024-07-25 | ダウングレード | JP Morgan | Overweight → Neutral |
| 2024-07-25 | ダウングレード | Robert W. Baird | Outperform → Neutral |
| 2024-07-25 | ダウングレード | TD Cowen | Buy → Hold |
| 2024-07-25 | ダウングレード | Truist | Buy → Hold |
| 2024-05-30 | 開始されました | Goldman | Buy |
| 2024-05-22 | アップグレード | Citigroup | Neutral → Buy |
| 2024-05-14 | アップグレード | Deutsche Bank | Hold → Buy |
| 2024-03-07 | アップグレード | BofA Securities | Neutral → Buy |
| 2024-02-02 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2024-01-04 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2023-12-11 | ダウングレード | Citigroup | Buy → Neutral |
| 2023-11-28 | ダウングレード | Wolfe Research | Peer Perform → Underperform |
| 2023-09-26 | アップグレード | Oppenheimer | Perform → Outperform |
| 2023-07-19 | 開始されました | Robert W. Baird | Outperform |
| 2023-05-30 | 再開されました | Morgan Stanley | Overweight |
| 2023-03-29 | 開始されました | UBS | Neutral |
| 2023-03-08 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2023-02-06 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-01-31 | ダウングレード | Bernstein | Outperform → Underperform |
| 2023-01-30 | ダウングレード | Piper Sandler | Overweight → Neutral |
| 2022-12-06 | ダウングレード | Stifel | Buy → Hold |
| 2022-10-28 | ダウングレード | Oppenheimer | Outperform → Perform |
| 2022-10-26 | 開始されました | Mizuho | Buy |
| 2022-10-18 | 開始されました | Barclays | Overweight |
| 2022-10-12 | 開始されました | Jefferies | Buy |
| 2022-07-29 | ダウングレード | Canaccord Genuity | Buy → Hold |
| 2022-04-13 | 開始されました | Truist | Buy |
| 2022-04-06 | 開始されました | Wolfe Research | Outperform |
| 2022-03-16 | アップグレード | Bernstein | Mkt Perform → Outperform |
| 2022-03-02 | 再開されました | BofA Securities | Neutral |
| 2022-02-02 | アップグレード | UBS | Neutral → Buy |
| 2022-01-27 | 繰り返されました | Citigroup | Buy |
| 2022-01-27 | 繰り返されました | Evercore ISI | Outperform |
| 2022-01-27 | 繰り返されました | Raymond James | Outperform |
| 2022-01-27 | 繰り返されました | Stifel | Buy |
| 2022-01-27 | 繰り返されました | UBS | Neutral |
| 2021-12-17 | アップグレード | JP Morgan | Neutral → Overweight |
| 2021-12-15 | アップグレード | Citigroup | Neutral → Buy |
| 2021-12-10 | 開始されました | RBC Capital Mkts | Outperform |
| 2021-12-06 | アップグレード | Wells Fargo | Equal Weight → Overweight |
| 2021-07-30 | 繰り返されました | Canaccord Genuity | Buy |
| 2021-07-30 | 繰り返されました | Deutsche Bank | Hold |
| 2021-07-30 | 繰り返されました | Jefferies | Buy |
| 2021-07-30 | 繰り返されました | Morgan Stanley | Overweight |
| 2021-07-30 | 繰り返されました | Oppenheimer | Outperform |
| 2021-07-30 | 繰り返されました | Stifel | Buy |
| 2021-07-30 | 繰り返されました | UBS | Neutral |
| 2021-07-30 | 繰り返されました | Wells Fargo | Equal Weight |
| 2021-05-25 | 開始されました | Barclays | Overweight |
| 2021-04-15 | 開始されました | Atlantic Equities | Neutral |
| 2021-04-05 | アップグレード | Evercore ISI | In-line → Outperform |
| 2020-12-16 | ダウングレード | Citigroup | Buy → Neutral |
| 2020-12-11 | 繰り返されました | Canaccord Genuity | Buy |
| 2020-09-11 | 開始されました | Wolfe Research | Underperform |
| 2020-04-28 | ダウングレード | Wells Fargo | Overweight → Equal Weight |
| 2020-04-17 | アップグレード | SVB Leerink | Mkt Perform → Outperform |
| 2020-03-05 | 開始されました | Citigroup | Buy |
| 2020-02-13 | 開始されました | Goldman | Neutral |
| 2020-02-06 | 再開されました | BTIG Research | Neutral |
| 2020-01-10 | 開始されました | Oppenheimer | Outperform |
| 2020-01-02 | ダウングレード | Evercore ISI | Outperform → In-line |
| 2019-10-24 | 繰り返されました | Canaccord Genuity | Buy |
| 2019-09-23 | 開始されました | Piper Jaffray | Overweight |
| 2019-07-24 | 繰り返されました | BofA/Merrill | Buy |
| 2019-03-18 | 繰り返されました | Canaccord Genuity | Buy |
| 2019-01-18 | アップグレード | BofA/Merrill | Neutral → Buy |
| 2019-01-03 | 開始されました | Deutsche Bank | Hold |
| 2018-11-28 | 開始されました | UBS | Neutral |
| 2018-10-16 | 開始されました | Barclays | Underweight |
| 2018-10-02 | ダウングレード | BofA/Merrill | Buy → Neutral |
| 2018-10-02 | ダウングレード | Guggenheim | Buy → Neutral |
すべてを表示
Edwards Lifesciences Corp (EW) 最新ニュース
Boston Scientific’s $1.5B bet signals heart valve market battle - Modern Healthcare News
Edwards Lifesciences Corp. Hits New 52-Week High at USD 87.93 - Markets Mojo
Allstate Corp Grows Stock Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences CVP Donald Bobo Jr. sells $2m in stock By Investing.com - Investing.com Australia
Edwards Lifesciences CVP Donald Bobo Jr. sells $2m in stock - Investing.com Australia
Edwards Lifesciences (EW) executive sells 23,145 shares at $86.42 average price - Stock Titan
Edwards Lifesciences Corp. stock underperforms Wednesday when compared to competitors - MarketWatch
Donald Bobo reports multiple Common stock sales (EW) in Form 144 - Stock Titan
Edwards Lifesciences Has Everything Investors Want Except Value (NYSE:EW) - Seeking Alpha
Legal & General Group Plc Has $376.46 Million Stake in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corp. stock outperforms competitors on strong trading day - MarketWatch
Edwards Lifesciences stock hits 52-week high at 87.89 USD - Investing.com
Swedbank AB Lowers Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences’ SWOT analysis: stock gains from rival’s setback By Investing.com - Investing.com Australia
Edwards Lifesciences’ SWOT analysis: stock gains from rival’s setback - Investing.com
Edwards Lifesciences Corp. (EW) Stock Analysis: Healthcare Giant with 13% Upside Potential - DirectorsTalk Interviews
Edwards Lifesciences Corporation (NYSE:EW) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
Edwards Lifesciences Corporation $EW Shares Sold by Rathbones Group PLC - MarketBeat
ABN Amro Investment Solutions Raises Stock Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
Insider Sell Alert: Daveen Chopra Sells Shares of Edwards Lifesc - GuruFocus
Analysts Offer Insights on Healthcare Companies: P3 Health Partners (PIII) and Edwards Lifesciences (EW) - The Globe and Mail
Edwards Lifesciences Corp (EW) Stock Up 3.1% and Still Undervalued -- GF Score: 95/100 - GuruFocus
Edwards Lifesciences (NYSE: EW) exec sells 1,500 common shares - Stock Titan
Edwards Lifesciences (EW) Form 144: Broker-listed proposed sale notice - Stock Titan
19,073 Shares in Edwards Lifesciences Corporation $EW Purchased by Fideuram Intesa Sanpaolo Private Banking S.P.A. - MarketBeat
Investment House LLC Trims Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
North Dakota State Investment Board Buys Shares of 19,728 Edwards Lifesciences Corporation $EW - MarketBeat
Handelsbanken Fonder AB Has $102.60 Million Stock Position in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences CVP Lippis sells $50,306 of common stock By Investing.com - Investing.com Nigeria
Insider Sell Alert: Daniel Lippis Sells Shares of Edwards Lifesc - GuruFocus
Edwards Lifesciences (NYSE:EW) VP Sells $50,306.80 in Stock - MarketBeat
Edwards Lifesciences CVP Lippis sells $50,306 of common stock - Investing.com India
Edwards Lifesciences CVP, Strategy/Corp Development Sold Shares Worth Over $1.4M - TradingView
Edwards Lifesciences exec sells 620 shares after option exercise | EW Insider Trading - Stock Titan
Edwards Lifesciences (EW) CVP Donald Bobo Jr. sells 17,968 shares in open-market trades - Stock Titan
Edwards Lifesciences Corp. stock underperforms Monday when compared to competitors despite daily gains - MarketWatch
Edwards Lifesciences (NYSE: EW) Form 144 lists 150,758 units via broker - Stock Titan
Northwestern Mutual Wealth Management Co. Purchases 1,093,692 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
[144] Edwards Lifesciences Corp SEC Filing - Stock Titan
Edwards Lifesciences Corporation $EW Stock Position Boosted by Bank Julius Baer & Co. Ltd Zurich - MarketBeat
Top Edwards Lifesciences (EW) Competitors 2026 - MarketBeat
Are Wall Street Analysts Bullish on Edwards Lifesciences Stock? - Yahoo Finance
Scaling heart valve manufacturing to deliver life-saving treatments across Europe - Jacobs
VIRGINIA RETIREMENT SYSTEMS ET Al Trims Stake in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences' (NYSE:EW) Conservative Accounting Might Explain Soft Earnings - Yahoo Finance
[Form 4] Edwards Lifesciences Corp Insider Trading Activity - Stock Titan
Edwards Lifesciences CEO Zovighian sells $2.83m in shares By Investing.com - Investing.com Nigeria
Edwards Lifesciences CEO Zovighian sells $2.83m in shares - Investing.com
Edwards Lifesciences (EW) CVP exercises 13,457 performance shares with 7,469 withheld for taxes - Stock Titan
Edwards Lifesciences (EW) executive vests performance units and withholds shares for taxes - Stock Titan
Edwards Lifesciences (NYSE: EW) lists vested RSUs and prior 22,430-share sale - Stock Titan
Edwards Lifesciences Corp (EW) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):